Similar articles

• Parecoxib inhibits apoptosis in acute myocardial infarction due to permanent coronary ligation but not due to ischemia-reperfusion.

  Salloum FN, Hoke NN, Seropian IM, Varma A, Ownby ED, Houser JE, Van Tassell BW, Abbate A. Salloum FN, et al. J Cardiovasc Pharmacol. 2009 Jun;53(6):495-8. doi: 10.1097/FJC.0b013e3181a7b5b6. J Cardiovasc Pharmacol. 2009. PMID: 19455055
• Protective effects of parecoxib, a cyclo-oxygenase-2 inhibitor, in postinfarction remodeling in the rat.

  Straino S, Salloum FN, Baldi A, Ockaili RA, Piro M, Das A, Qureshi IZ, Biasucci LM, Capogrossi MC, Biondi-Zoccai GG, Severino A, Mellone P, Crea F, Vetrovec GW, Kukreja RC, Abbate A. Straino S, et al. J Cardiovasc Pharmacol. 2007 Nov;50(5):571-7. doi: 10.1097/FJC.0b013e31814b91cb. J Cardiovasc Pharmacol. 2007. PMID: 18030068
• Cyclooxygenase-2 suppresses polymorphonuclear neutrophil apoptosis after acute lung injury.

  Jinzhou Z, Tao H, Wensheng C, Wen W, Jincheng L, Qin C, Hailong Z, Weiyong L, Dinghua Y. Jinzhou Z, et al. J Trauma. 2008 Apr;64(4):1055-60. doi: 10.1097/TA.0b013e318047c07c. J Trauma. 2008. PMID: 18404075
• Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process.

  Vuolteenaho K, Moilanen T, Moilanen E. Vuolteenaho K, et al. Basic Clin Pharmacol Toxicol. 2008 Jan;102(1):10-4. doi: 10.1111/j.1742-7843.2007.00149.x. Epub 2007 Oct 31. Basic Clin Pharmacol Toxicol. 2008. PMID: 17973900 Review.
• Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors.

  Grösch S, Maier TJ, Schiffmann S, Geisslinger G. Grösch S, et al. J Natl Cancer Inst. 2006 Jun 7;98(11):736-47. doi: 10.1093/jnci/djj206. J Natl Cancer Inst. 2006. PMID: 16757698 Review.